公司資料
Protagenic Therapeutics 股價、新聞與催化劑
- 股票代碼:
- PTIX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.36 USD (0.00%)
收盤價
最後更新: 2026年8月14日
—
市值
股價為何變動
Current closing-price context is not available for PTIX.
公司概覽
業務概覽
Protagenic Therapeutics is a biotechnology company focused on neuropsychiatric and stress-related disorders. Its story is built around the idea that peptide-based or related approaches can address difficult CNS conditions.
所在地與產業分類
Protagenic is headquartered in the United States and listed on NASDAQ. It sits in small-cap neuroscience biotechnology.
商業模式特徵
The company depends on preclinical and early clinical validation, translational credibility, and capital support. Investors typically watch early data, pipeline prioritization, and whether the company can narrow its story into a viable CNS thesis.
生技產業定位
Protagenic occupies a speculative neuroscience niche within biotech. It is a high-risk story where platform proof matters more than near-term commercial scale.
未來催化劑
- Protagenic’s catalysts are neuropeptide and CNS programs, with any update that clarifies whether the company can still produce meaningful development progress. The stock needs a cleaner clinical path.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。